Six finalists have been selected out of 34 applications from across the globe for the 3rd annual Global Impact Award (GIA). The finalists will compete for a prize of up to $50,000 during the final event that will be held this November at Washington University in St. Louis.
The finalists are:
- Epharmix: Builds disease-specific, automated, interactive communication tools that track patients’ conditions;
- Geneoscopy: A colon cancer detection method through take-home stool tests;
- Aerial Insights: Uses integrated UAV data acquisition and analytics solution for utilities, agriculture and industrial uses;
- Rare Genomics: A patient-centered and science driven ecosystem that leverages the power of crowdfunding and social media to empower those affected by rare diseases to accelerate research and find hope for a cure; and
- Women’s Bakery: A social enterprise based in East Africa that trains women with nutrition, business, baking, and life skills to launch bakeries selling affordable, nutritious bread.
- Chrona Sleep: Chrona synchronizes the user’s brainwave activity using specialized low-frequency sounds to help the user sleep more deeply and to deliver more efficient rest.
Hosted by the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship, the competition is made possible by alumnus Suren G. Dutia and his wife, Jas K. Grewal. It is geared toward early-stage startups, and its mission is to support the vision and passion of Washington University students, postdoctoral researchers, and recent alumni who are creating ventures that are scalable, sustainable and quick-to-market with proof of concept and a broad impact.
Read more on the Skandalaris Center website.